trending Market Intelligence /marketintelligence/en/news-insights/trending/Tvye0Pk89JxrG9cQufqPUQ2 content esgSubNav
In This List

Dimension Therapeutics adds director

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Dimension Therapeutics adds director

Dimension Therapeutics Inc. appointed John Hohneker, an executive vice president and head of research and development at FORMA Therapeutics Inc., to its board of directors, effective Jan. 18.

Hohneker will serve as a class 1 director until Dimension's next annual stockholders' meeting following Dec. 31, 2018.